CJC-1295 No DAC + Ipamorelin vs Sermorelin: What’s the Difference?
The main difference between CJC-1295 No DAC + Ipamorelin and Sermorelin is mechanism: CJC-1295 No DAC + Ipamorelin is studied for the most-discussed gh-secretagogue research stack — CJC-1295 increases GHRH-receptor amplitude; ipamorelin activates the ghrelin receptor (GHSR) to trigger GH release — the two pathways are synergistic. Sermorelin is studied for endogenous gh-release research — Classic GHRH analog (29 amino acids).
Combined GHRH+GHRP synergy vs single GHRH analog.
Key differences between CJC-1295 No DAC + Ipamorelin and Sermorelin
- •Mechanism: CJC-1295 No DAC + Ipamorelin — CJC-1295 increases GHRH-receptor amplitude; ipamorelin activates the ghrelin receptor (GHSR) to trigger GH release — the two pathways are synergistic. Sermorelin — Classic GHRH analog (29 amino acids).
- •Primary research focus: CJC-1295 No DAC + Ipamorelin is studied for the most-discussed gh-secretagogue research stack; Sermorelin is studied for endogenous gh-release research.
- •Overlap: the two compounds share muscle growth & performance.
- •Discussion context: CJC-1295 No DAC + Ipamorelin is most often discussed alongside the most-discussed gh-secretagogue research stack, while Sermorelin centres on endogenous gh-release research.
| Attribute | CJC-1295 No DAC + Ipamorelin The Classic GH Stack | Sermorelin GHRH(1-29) |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | The most-discussed GH-secretagogue research stack | Endogenous GH-release research |
| Mechanism of action | CJC-1295 increases GHRH-receptor amplitude; ipamorelin activates the ghrelin receptor (GHSR) to trigger GH release — the two pathways are synergistic. | Classic GHRH analog (29 amino acids). Mild, well-tolerated GH release. |
| Human research | Not catalogued | Moderate |
| Animal research | Not catalogued | Moderate |
| Mechanistic research | Not catalogued | Established |
| Study cadence cited | — | Daily before bed (commonly 5 nights on, 2 off) |
| In plain English | CJC-1295 widens the pipe; ipamorelin opens the faucet. Together they create a larger, cleaner GH pulse than either alone. | The original GH peptide. Sermorelin is shorter-acting and milder than CJC-1295 — researchers consider it the gentle introduction to GH peptide research. |
| How it works | CJC-1295 increases GHRH-receptor amplitude; ipamorelin activates the ghrelin receptor (GHSR) to trigger GH release — the two pathways are synergistic. | Stimulates pituitary GH release by binding the GHRH receptor. |
| Researchers study | IGF-1 elevation, sleep quality, recovery, and lean-mass research. | Age-related GH decline, body composition, sleep, and pediatric GH deficiency. |
| Internet discussion | The default first GH-secretagogue stack on r/Peptides. | Older audience favors it for being well-studied with a long history. |
Mechanism and research evidence, side by side
How CJC-1295 No DAC + Ipamorelin and Sermorelin differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
Sermorelin
Classic GHRH analog (29 amino acids). Mild, well-tolerated GH release.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Anti-aging, sleep quality, recovery, mild GH support
CJC-1295 No DAC + Ipamorelin
The most-discussed GH-secretagogue research stack
CJC-1295 widens the pipe; ipamorelin opens the faucet. Together they create a larger, cleaner GH pulse than either alone.
CJC-1295 increases GHRH-receptor amplitude; ipamorelin activates the ghrelin receptor (GHSR) to trigger GH release — the two pathways are synergistic.
IGF-1 elevation, sleep quality, recovery, and lean-mass research.
The default first GH-secretagogue stack on r/Peptides.
CJC-1295 no-DAC + ipamorelin is the most-discussed GHRH/GHRP research stack for natural GH pulse amplification.
Sermorelin
Endogenous GH-release research
The original GH peptide. Sermorelin is shorter-acting and milder than CJC-1295 — researchers consider it the gentle introduction to GH peptide research.
Stimulates pituitary GH release by binding the GHRH receptor.
Age-related GH decline, body composition, sleep, and pediatric GH deficiency.
Older audience favors it for being well-studied with a long history.
Sermorelin is the original GHRH analog with the longest research history in GH peptide work.